4 Firms Guide As Arcline Exits Medical Tech Co. In $685M Deal
Wednesday, March 4, 2026 · first reported by Law360
Arcline exited its medical technology company investment for $685 million with guidance from four major law firms, indicating a complex and high-profile transaction. The deal demonstrates active PE portfolio management and exit execution.
- Firm
- Arcline
- Deal value
- $685M
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Arcline
Everything on this firm →- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets